1α,25(OH)2-3-epi-vitamin D3, a natural physiological metabolite of vitamin D3: its synthesis, biological activity and crystal structure with its receptor.
<h4>Background</h4>The 1α,25-dihydroxy-3-epi-vitamin-D3 (1α,25(OH)2-3-epi-D3), a natural metabolite of the seco-steroid vitamin D3, exerts its biological activity through binding to its cognate vitamin D nuclear receptor (VDR), a ligand dependent transcription regulator. In vivo action o...
Guardado en:
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2011
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/25a28b670f684904a71dbf40fb88d15a |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:25a28b670f684904a71dbf40fb88d15a |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:25a28b670f684904a71dbf40fb88d15a2021-11-18T06:56:26Z1α,25(OH)2-3-epi-vitamin D3, a natural physiological metabolite of vitamin D3: its synthesis, biological activity and crystal structure with its receptor.1932-620310.1371/journal.pone.0018124https://doaj.org/article/25a28b670f684904a71dbf40fb88d15a2011-03-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21483824/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>The 1α,25-dihydroxy-3-epi-vitamin-D3 (1α,25(OH)2-3-epi-D3), a natural metabolite of the seco-steroid vitamin D3, exerts its biological activity through binding to its cognate vitamin D nuclear receptor (VDR), a ligand dependent transcription regulator. In vivo action of 1α,25(OH)2-3-epi-D3 is tissue-specific and exhibits lowest calcemic effect compared to that induced by 1α,25(OH)2D3. To further unveil the structural mechanism and structure-activity relationships of 1α,25(OH)2-3-epi-D3 and its receptor complex, we characterized some of its in vitro biological properties and solved its crystal structure complexed with human VDR ligand-binding domain (LBD).<h4>Methodology/principal findings</h4>In the present study, we report the more effective synthesis with fewer steps that provides higher yield of the 3-epimer of the 1α,25(OH)2D3. We solved the crystal structure of its complex with the human VDR-LBD and found that this natural metabolite displays specific adaptation of the ligand-binding pocket, as the 3-epimer maintains the number of hydrogen bonds by an alternative water-mediated interaction to compensate the abolished interaction with Ser278. In addition, the biological activity of the 1α,25(OH)2-3-epi-D3 in primary human keratinocytes and biochemical properties are comparable to 1α,25(OH)2D3.<h4>Conclusions/significance</h4>The physiological role of this pathway as the specific biological action of the 3-epimer remains unclear. However, its high metabolic stability together with its significant biologic activity makes this natural metabolite an interesting ligand for clinical applications. Our new findings contribute to a better understanding at molecular level how natural metabolites of 1α,25(OH)2D3 lead to significant activity in biological systems and we conclude that the C3-epimerization pathway produces an active metabolite with similar biochemical and biological properties to those of the 1α,25(OH)2D3.Ferdinand MolnárRita SigüeiroYoshiteru SatoClarisse AraujoInge SchusterPierre AntonyJean PelusoChristian MullerAntonio MouriñoDino MorasNatacha RochelPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 6, Iss 3, p e18124 (2011) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Ferdinand Molnár Rita Sigüeiro Yoshiteru Sato Clarisse Araujo Inge Schuster Pierre Antony Jean Peluso Christian Muller Antonio Mouriño Dino Moras Natacha Rochel 1α,25(OH)2-3-epi-vitamin D3, a natural physiological metabolite of vitamin D3: its synthesis, biological activity and crystal structure with its receptor. |
| description |
<h4>Background</h4>The 1α,25-dihydroxy-3-epi-vitamin-D3 (1α,25(OH)2-3-epi-D3), a natural metabolite of the seco-steroid vitamin D3, exerts its biological activity through binding to its cognate vitamin D nuclear receptor (VDR), a ligand dependent transcription regulator. In vivo action of 1α,25(OH)2-3-epi-D3 is tissue-specific and exhibits lowest calcemic effect compared to that induced by 1α,25(OH)2D3. To further unveil the structural mechanism and structure-activity relationships of 1α,25(OH)2-3-epi-D3 and its receptor complex, we characterized some of its in vitro biological properties and solved its crystal structure complexed with human VDR ligand-binding domain (LBD).<h4>Methodology/principal findings</h4>In the present study, we report the more effective synthesis with fewer steps that provides higher yield of the 3-epimer of the 1α,25(OH)2D3. We solved the crystal structure of its complex with the human VDR-LBD and found that this natural metabolite displays specific adaptation of the ligand-binding pocket, as the 3-epimer maintains the number of hydrogen bonds by an alternative water-mediated interaction to compensate the abolished interaction with Ser278. In addition, the biological activity of the 1α,25(OH)2-3-epi-D3 in primary human keratinocytes and biochemical properties are comparable to 1α,25(OH)2D3.<h4>Conclusions/significance</h4>The physiological role of this pathway as the specific biological action of the 3-epimer remains unclear. However, its high metabolic stability together with its significant biologic activity makes this natural metabolite an interesting ligand for clinical applications. Our new findings contribute to a better understanding at molecular level how natural metabolites of 1α,25(OH)2D3 lead to significant activity in biological systems and we conclude that the C3-epimerization pathway produces an active metabolite with similar biochemical and biological properties to those of the 1α,25(OH)2D3. |
| format |
article |
| author |
Ferdinand Molnár Rita Sigüeiro Yoshiteru Sato Clarisse Araujo Inge Schuster Pierre Antony Jean Peluso Christian Muller Antonio Mouriño Dino Moras Natacha Rochel |
| author_facet |
Ferdinand Molnár Rita Sigüeiro Yoshiteru Sato Clarisse Araujo Inge Schuster Pierre Antony Jean Peluso Christian Muller Antonio Mouriño Dino Moras Natacha Rochel |
| author_sort |
Ferdinand Molnár |
| title |
1α,25(OH)2-3-epi-vitamin D3, a natural physiological metabolite of vitamin D3: its synthesis, biological activity and crystal structure with its receptor. |
| title_short |
1α,25(OH)2-3-epi-vitamin D3, a natural physiological metabolite of vitamin D3: its synthesis, biological activity and crystal structure with its receptor. |
| title_full |
1α,25(OH)2-3-epi-vitamin D3, a natural physiological metabolite of vitamin D3: its synthesis, biological activity and crystal structure with its receptor. |
| title_fullStr |
1α,25(OH)2-3-epi-vitamin D3, a natural physiological metabolite of vitamin D3: its synthesis, biological activity and crystal structure with its receptor. |
| title_full_unstemmed |
1α,25(OH)2-3-epi-vitamin D3, a natural physiological metabolite of vitamin D3: its synthesis, biological activity and crystal structure with its receptor. |
| title_sort |
1α,25(oh)2-3-epi-vitamin d3, a natural physiological metabolite of vitamin d3: its synthesis, biological activity and crystal structure with its receptor. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2011 |
| url |
https://doaj.org/article/25a28b670f684904a71dbf40fb88d15a |
| work_keys_str_mv |
AT ferdinandmolnar 1a25oh23epivitamind3anaturalphysiologicalmetaboliteofvitamind3itssynthesisbiologicalactivityandcrystalstructurewithitsreceptor AT ritasigueiro 1a25oh23epivitamind3anaturalphysiologicalmetaboliteofvitamind3itssynthesisbiologicalactivityandcrystalstructurewithitsreceptor AT yoshiterusato 1a25oh23epivitamind3anaturalphysiologicalmetaboliteofvitamind3itssynthesisbiologicalactivityandcrystalstructurewithitsreceptor AT clarissearaujo 1a25oh23epivitamind3anaturalphysiologicalmetaboliteofvitamind3itssynthesisbiologicalactivityandcrystalstructurewithitsreceptor AT ingeschuster 1a25oh23epivitamind3anaturalphysiologicalmetaboliteofvitamind3itssynthesisbiologicalactivityandcrystalstructurewithitsreceptor AT pierreantony 1a25oh23epivitamind3anaturalphysiologicalmetaboliteofvitamind3itssynthesisbiologicalactivityandcrystalstructurewithitsreceptor AT jeanpeluso 1a25oh23epivitamind3anaturalphysiologicalmetaboliteofvitamind3itssynthesisbiologicalactivityandcrystalstructurewithitsreceptor AT christianmuller 1a25oh23epivitamind3anaturalphysiologicalmetaboliteofvitamind3itssynthesisbiologicalactivityandcrystalstructurewithitsreceptor AT antoniomourino 1a25oh23epivitamind3anaturalphysiologicalmetaboliteofvitamind3itssynthesisbiologicalactivityandcrystalstructurewithitsreceptor AT dinomoras 1a25oh23epivitamind3anaturalphysiologicalmetaboliteofvitamind3itssynthesisbiologicalactivityandcrystalstructurewithitsreceptor AT natacharochel 1a25oh23epivitamind3anaturalphysiologicalmetaboliteofvitamind3itssynthesisbiologicalactivityandcrystalstructurewithitsreceptor |
| _version_ |
1718424156324757504 |